EIKN — Eikon Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $322.12m
- $322.12m
- 12
- 35
- 32
- 14
Annual balance sheet for Eikon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 430 | 220 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 436 | 228 |
| Net Property, Plant And Equipment | 86.9 | 259 |
| Other Long Term Assets | ||
| Total Assets | 526 | 491 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 31.4 | 56.4 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 58.9 | 255 |
| Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 467 | 236 |
| Total Liabilities & Shareholders' Equity | 526 | 491 |
| Total Common Shares Outstanding |